a magnifying glass

adobe pdf icon Analogic Corporation Receives 510(k) FDA Clearance for Wide-Beam Fetal Ultrasound Transducer

Analogic Corporation Receives 510(k) FDA Clearance for Wide-Beam Fetal Ultrasound Transducer

Analogic Corporation Receives 510(k) FDA Clearance for Wide-Beam Fetal Ultrasound Transducer

PEABODY, Mass.–(BUSINESS WIRE)–March 29, 2006–Analogic
Corporation (NASDAQ: ALOG) announced today that the U.S. Food & Drug
Administration (FDA) has given market clearance for a wide-beam fetal
ultrasound transducer designed for use with the recently released
FETALGARD Lite® – NIBP (Non-Invasive Blood Pressure) fetal monitor
and with the FETALGARD Lite, both of which are members of Analogic’s
growing LIFEGARD® family of patient and fetal monitors.

The single-crystal, wide-beam fetal ultrasound transducer is
designed to match the current performance levels of the multi-crystal
transducers in the marketplace today. Unlike older, multi-crystal
designs, the new transducer has a smooth beam pattern with no nulls,
producing a smooth, consistent Fetal Heart Rate (FHR) signal. The
transducer is small–about the size of a U.S. silver
dollar–lightweight, and thus very comfortable for the patient.
Because of its sealed construction, the wide-beam transducer has the
additional advantage of being waterproof for use in those situations
where water emersion is used to reduce stress in labor.

Dan Webster, General Manager of Analogic’s Life Care Systems
Division, noted, “We’re pleased to add the new wide-beam,
single-crystal fetal monitor to Analogic’s comprehensive line of
general-purpose and specialized patient monitors and monitoring
products. All Analogic patient monitors and accessories are designed
to meet the specific needs of clinicians in a variety of settings,
including the physician’s office, a clinic, or the home.”

Analogic’s LIFEGARD family of non-invasive patient monitors
includes LIFEGARD, a general-purpose monitor that measures ECG, heart
rate, respiration, pulse oximetry, non-invasive blood pressure, and
temperature; LIFEGARD ICG, a non-invasive hemodynamic status monitor;
LIFEGARD II, a multiparameter monitor that offers non-invasive cardiac
output and end tidal CO2; FETALGARD Lite, an antepartum fetal monitor
with twins capability; and FETALGARD Lite – NIBP, which measures
non-invasive blood pressure for monitoring Pregnancy-Induced
Hypertension (PIH).

Analogic’s LIFEGARD series of non-invasive patient monitors,
accessories, and consumables are available to order online directly
from Analogic. To place an order, or to obtain more information on any
LIFEGARD product, please go to www.analogic.com/lifegard or call
800-599-7769. Online pricing and ordering are currently limited to
products to be delivered in the U.S.

Analogic Corporation is a leading designer and manufacturer of
advanced health and security systems and subsystems sold primarily to
Original Equipment Manufacturers (OEMs). The Company is recognized
worldwide for advancing the state of the art in Computed Tomography
(CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging
(MRI), Patient Monitoring, and Embedded Multiprocessing.

CONTACT: Analogic Corporation
Paul M. Roberts, 978-326-4213
Director of Communications

SOURCE: Analogic Corporation